Meningococcal vaccine - AchilleS Vaccines/University of Cambridge
Alternative Names: MenOMVax; Multivalent universal pan-meningococcal vaccine - AchilleS VaccinesLatest Information Update: 28 Jul 2024
At a glance
- Originator AchilleS Vaccines
- Developer AchilleS Vaccines; University of Cambridge
- Class Meningococcal vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Meningococcal infections
Most Recent Events
- 28 Jul 2024 No recent reports of development identified for research development in Meningococcal-infections in Italy (Parenteral)
- 28 Jul 2024 No recent reports of development identified for research development in Meningococcal-infections in United Kingdom (Parenteral)